Danaher Depreciation decreased by 1.0% to $193.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $181.00M to $193.00M. Over 4 years (FY 2021 to FY 2025), Depreciation shows an upward trend with a 2.7% CAGR.
Higher depreciation relative to capital expenditures may suggest aging assets, while lower levels relative to revenue may indicate high asset efficiency.
Depreciation is a non-cash accounting charge that allocates the cost of tangible assets over their useful lives. It refl...
Standardized for capital-intensive industries; peers in manufacturing typically show significant depreciation expenses.
operating_depreciation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $178.00M | $189.00M | $149.00M | $179.00M | $179.00M | $179.00M | $161.00M | $163.00M | $168.00M | $166.00M | $178.00M | $179.00M | $178.00M | $177.00M | $187.00M | $181.00M | $185.00M | $189.00M | $195.00M | $193.00M |
| QoQ Change | — | +6.2% | -21.2% | +20.1% | +0.0% | +0.0% | -10.1% | +1.2% | +3.1% | -1.2% | +7.2% | +0.6% | -0.6% | -0.6% | +5.6% | -3.2% | +2.2% | +2.2% | +3.2% | -1.0% |
| YoY Change | — | — | — | — | +0.6% | -5.3% | +8.1% | -8.9% | -6.1% | -7.3% | +10.6% | +9.8% | +6.0% | +6.6% | +5.1% | +1.1% | +3.9% | +6.8% | +4.3% | +6.6% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Diagnostics | — | — | — | $102.00M |
| Life Sciences | — | — | — | $48.00M |
| Biotechnology | $34.00M | $38.00M | $38.00M | $40.00M |
| Total | $181.00M | $185.00M | $189.00M | $193.00M |